Literature DB >> 18491294

Creation of "humanized" mice to study human immunity.

Todd Pearson1, Dale L Greiner, Leonard D Shultz.   

Abstract

"Humanized" mice are a promising translational model for studying human hematopoiesis and immunity. Their utility has been enhanced by the development of new stocks of immunodeficient hosts, most notably mouse strains such as NOD-scid IL2rgamma(null) mice that lack the IL-2 receptor common gamma chain. These stocks of mice lack adaptive immune function, display multiple defects in innate immunity, and support heightened levels of human hematolymphoid engraftment. Humanized mice can support studies in many areas of immunology, including autoimmunity, transplantation, infectious diseases, and cancer. These models are particularly valuable in experimentation where there is no appropriate small animal model of the human disease, as in the case of certain viral infections. This unit details the creation of humanized mice by engraftment of immunodeficient mice with hematopoietic stem cells or peripheral blood mononuclear cells, provides methods for evaluating engraftment, and discusses considerations for choosing the appropriate model system to meet specific goals. Copyright 2008 by John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18491294      PMCID: PMC3023233          DOI: 10.1002/0471142735.im1521s81

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  20 in total

1.  Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow.

Authors:  T L Holyoake; F E Nicolini; C J Eaves
Journal:  Exp Hematol       Date:  1999-09       Impact factor: 3.084

2.  Development of a human adaptive immune system in cord blood cell-transplanted mice.

Authors:  Elisabetta Traggiai; Laurie Chicha; Luca Mazzucchelli; Lucio Bronz; Jean-Claude Piffaretti; Antonio Lanzavecchia; Markus G Manz
Journal:  Science       Date:  2004-04-02       Impact factor: 47.728

3.  NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.

Authors:  Mamoru Ito; Hidefumi Hiramatsu; Kimio Kobayashi; Kazutomo Suzue; Mariko Kawahata; Kyoji Hioki; Yoshito Ueyama; Yoshio Koyanagi; Kazuo Sugamura; Kohichiro Tsuji; Toshio Heike; Tatsutoshi Nakahata
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

4.  Monitoring the effect of gene silencing by RNA interference in human CD34+ cells injected into newborn RAG2-/- gammac-/- mice: functional inactivation of p53 in developing T cells.

Authors:  Ramon Gimeno; Kees Weijer; Arie Voordouw; Christel H Uittenbogaart; Nicolas Legrand; Nuno L Alves; Erwin Wijnands; Bianca Blom; Hergen Spits
Journal:  Blood       Date:  2004-08-19       Impact factor: 22.113

5.  A severe combined immunodeficiency mutation in the mouse.

Authors:  G C Bosma; R P Custer; M J Bosma
Journal:  Nature       Date:  1983-02-10       Impact factor: 49.962

6.  Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain.

Authors:  X Cao; E W Shores; J Hu-Li; M R Anver; B L Kelsall; S M Russell; J Drago; M Noguchi; A Grinberg; E T Bloom
Journal:  Immunity       Date:  1995-03       Impact factor: 31.745

Review 7.  Humanized SCID mouse models for biomedical research.

Authors:  T Pearson; D L Greiner; L D Shultz
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

8.  Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.

Authors:  Scott J Banuelos; Leonard D Shultz; Dale L Greiner; Lisa M Burzenski; Bruce Gott; Bonnie L Lyons; Aldo A Rossini; Michael C Appel
Journal:  Clin Immunol       Date:  2004-09       Impact factor: 3.969

9.  Alloimmune injury and rejection of human skin grafts on human peripheral blood lymphocyte-reconstituted non-obese diabetic severe combined immunodeficient beta2-microglobulin-null mice.

Authors:  Nicole A Turgeon; Scott J Banuelos; Leonard D Shultz; Bonnie L Lyons; Neal Iwakoshi; Dale L Greiner; John P Mordes; Aldo A Rossini; Michael C Appel
Journal:  Exp Biol Med (Maywood)       Date:  2003-10

10.  High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to human immunodeficiency virus type 1 infection in NOD/LtSz-scid/scid mice.

Authors:  R M Hesselton; D L Greiner; J P Mordes; T V Rajan; J L Sullivan; L D Shultz
Journal:  J Infect Dis       Date:  1995-10       Impact factor: 5.226

View more
  78 in total

Review 1.  Immune mechanisms of Concanavalin A model of autoimmune hepatitis.

Authors:  Hai-Xia Wang; Man Liu; Shun-Yan Weng; Jing-Jing Li; Chao Xie; Hong-Lin He; Wen Guan; Yun-Sheng Yuan; Jin Gao
Journal:  World J Gastroenterol       Date:  2012-01-14       Impact factor: 5.742

Review 2.  Humanized mice for immune checkpoint blockade in human solid tumors.

Authors:  Henry Yip; Carl Haupt; Grace Maresh; Xin Zhang; Li Li
Journal:  Am J Clin Exp Urol       Date:  2019-10-15

Review 3.  Mouse Models of Oncoimmunology in Hepatocellular Carcinoma.

Authors:  Erin Bresnahan; Katherine E Lindblad; Marina Ruiz de Galarreta; Amaia Lujambio
Journal:  Clin Cancer Res       Date:  2020-04-23       Impact factor: 12.531

4.  Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line.

Authors:  Jacqueline S Coats; Ineavely Baez; Cornelia Stoian; Terry-Ann M Milford; Xiaobing Zhang; Olivia L Francis; Ruijun Su; Kimberly J Payne
Journal:  J Vis Exp       Date:  2017-05-10       Impact factor: 1.355

5.  Anti-human CD117 antibody-mediated bone marrow niche clearance in nonhuman primates and humanized NSG mice.

Authors:  Hye-Sook Kwon; Aaron C Logan; Akanksha Chhabra; Wendy W Pang; Agnieszka Czechowicz; Keri Tate; Alan Le; Jessica Poyser; Roger Hollis; Benjamin V Kelly; Donald B Kohn; Irving L Weissman; Susan S Prohaska; Judith A Shizuru
Journal:  Blood       Date:  2019-01-07       Impact factor: 22.113

Review 6.  Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory Diseases.

Authors:  Iurii Koboziev; Yava Jones-Hall; John F Valentine; Cynthia Reinoso Webb; Kathryn L Furr; Matthew B Grisham
Journal:  Inflamm Bowel Dis       Date:  2015-07       Impact factor: 5.325

Review 7.  Murine Models of Sepsis and Trauma: Can We Bridge the Gap?

Authors:  Julie A Stortz; Steven L Raymond; Juan C Mira; Lyle L Moldawer; Alicia M Mohr; Philip A Efron
Journal:  ILAR J       Date:  2017-07-01

8.  Mice engrafted with human hematopoietic stem cells support a human myeloid cell inflammatory response in vivo.

Authors:  Andrew Baird; Chenliang Deng; Matthew H Eliceiri; Fatima Haghi; Xitong Dang; Raul Coimbra; Todd W Costantini; Bruce E Torbett; Brian P Eliceiri
Journal:  Wound Repair Regen       Date:  2016-10-04       Impact factor: 3.617

9.  Human immune system development and rejection of human islet allografts in spontaneously diabetic NOD-Rag1null IL2rgammanull Ins2Akita mice.

Authors:  Michael A Brehm; Rita Bortell; Philip Diiorio; Jean Leif; Joseph Laning; Amy Cuthbert; Chaoxing Yang; Mary Herlihy; Lisa Burzenski; Bruce Gott; Oded Foreman; Alvin C Powers; Dale L Greiner; Leonard D Shultz
Journal:  Diabetes       Date:  2010-06-22       Impact factor: 9.461

10.  Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivo.

Authors:  N A McNeer; E B Schleifman; A Cuthbert; M Brehm; A Jackson; C Cheng; K Anandalingam; P Kumar; L D Shultz; D L Greiner; W Mark Saltzman; P M Glazer
Journal:  Gene Ther       Date:  2012-10-18       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.